Therapeutic Drug Monitoring Industry to Grow at a CAGR of 9.4% by 2026
Therapeutic Drug Monitoring Market by Product (Consumables, Equipment-Immunoassay Analyzers, Chromatography & MS Detectors, Clin...View MoreTherapeutic Drug Monitoring Industry to Grow at a CAGR of 9.4% by 2026
Therapeutic Drug Monitoring Market by Product (Consumables, Equipment-Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers), Technology, Class of drugs, End user and Region - Global Forecast to 2026
The Global Therapeutic Drug Monitoring Market is projected to reach USD 2.7 billion by 2026 from USD 1.6 billion in 2020, at a CAGR of 9.4% during the forecast period. The growth of this market is majorly driven by the rising number of organ transplant procedures, the use of TDM across various therapeutic fields, the increasing preference for precision medicine, a growing focus on R&D related to TDM, and technological advancements in immunoassay instruments. However, the need for high capital investments and the reluctance of small hospitals to offer TDM services may restrain the growth of this market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443#antiepilepticdrugs#antibioticdrugs#immunosuppressantdrugs#antiarrhythmicdrugs#bronchodilatordrugs#psychoactivedrugs#therapeuticdrugmonitoring#growth#demand